Evidence map›Paper›PMID 22948977›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2012

Corticotropin-releasing factor (CRF)-induced disruption of attention in rats is blocked by the κ-opioid receptor antagonist JDTic.

Ashlee Van't Veer, Jessica M Yano, F Ivy Carroll, Bruce M Cohen, William A Carlezon

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06196385 (Efficacy Of Intensive Cervical Traction On Depression, Insomnia, Quality of Life In Patients With Cervical Radiculopathy), which is not on this map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06196385 nacompletednot on this mapstarted 2023, after this paper: background citation

Efficacy Of Intensive Cervical Traction On Depression, Insomnia, Quality of Life In Patients With Cervical Radiculopathy

TypeinterventionalSponsorCairo UniversityRan2023 to 2024Enrolled40ConditionsCervical RadiculopathyArmsintensive Cervical Traction
3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Interactions between thePhilosophical transactions of the Royal Society of London. Series B, Biological sciences · 2022
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Opioid Addiction, Genetic Susceptibility, and Medical Treatments: A Review.International journal of molecular sciences · 2019
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ashlee Van't VeerDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, MA, USA.
Jessica M Yano
F Ivy Carroll
Bruce M Cohen
William A Carlezon
McLean Hospital · USHarvard University · USRTI International · US

Funding

PHD TRAINING IN NEUROSCIENCET32MH020017 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JOHN ASSAD · 1997 to 2026
$15.8M
Roles of nuleus accumbens CREB and Kappa function in depressionR01MH063266 · NIMH · MC LEAN HOSPITAL (BELMONT, MA) · PI CARLEZON, WILLIAM A. · 2001 to 2025
$9.1M
Selective Opioid Antagonists as Medications for Drug AbuseR01DA009045 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI CARROLL, FRANK IVY · 1994 to 2014
$5.6M
NIDA NIH HHS DA009045NIDA NIH HHS R01 DA009045NIMH NIH HHS MH063266NIMH NIH HHS R01 MH063266NIMH NIH HHS T32 MH020017
6 · The paper itself

Abstract

Stress often disrupts behavior and can lead to psychiatric illness. Considerable evidence suggests that corticotropin-releasing factor (CRF) plays an important role in regulating the effects of stress. CRF administration produces stress-like effects in humans and laboratory animals, and CRF levels are elevated in individuals with stress-related illness. Recent work indicates that κ-opioid receptor (KOR) antagonists can block CRF effects, raising the possibility that at least some of the effects of stress are mediated via KORs. Here we examined the effects of CRF on performance in the 5-choice serial reaction time task (5CSRTT), a test used to quantify attention in rodents, as well as functional interactions between CRF and KORs. Male Sprague-Dawley rats were trained in the 5CSRTT and then each was implanted with an intracerebroventricular (ICV) cannula. After recovery and restabilization of performance, they received a single intraperitoneal (IP) injection of vehicle or JDTic (10 mg/kg), a KOR antagonist with long-lasting (>14 days) effects. In subsequent sessions, rats received ICV infusions of CRF (0.25-1.0 μg) or vehicle and were tested 60 min later. CRF dose-dependently disrupted performance as reflected by decreases in correct responding, increases in omission errors, increases in latencies to respond correctly, and increases in time to complete the session. JDTic attenuated each of these CRF-induced deficits while having no effects on its own. The persistent ability of JDTic to disrupt KOR function was confirmed using the tail immersion assay. These findings indicate that KOR antagonists can prevent acute stress-related effects that degrade performance in tasks requiring attention.

Indexed as

AnimalsAttentionCorticotropin-Releasing HormoneInjections, IntraventricularMaleNarcotic AntagonistsPiperidinesRatsRats, Sprague-DawleyReceptors, Opioid, kappaTetrahydroisoquinolines7-hydroxy-N-(1-((4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamideCorticotropin-Releasing HormoneNarcotic AntagonistsPiperidinesReceptors, Opioid, kappaTetrahydroisoquinolines

Identifiers

PMID22948977
PMCPMC3499711
OpenAlexW2080709600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.